Shuttle Pharmaceuticals Stock Today
| SHPH Stock | USD 0.42 0.01 2.44% |
PerformanceVery Weak
| Odds Of DistressVery High
|
Shuttle Pharmaceuticals is trading at 0.42 as of the 22nd of March 2025. This is a 2.44 percent increase since the beginning of the trading day. The stock's open price was 0.41. Shuttle Pharmaceuticals has a very high chance of experiencing financial distress in the next few years of operation. It has also generated negative returns for investors over the last 90 days. The performance scores are derived for the period starting the 22nd of December 2024 and ending today, the 22nd of March 2025. Click here to learn more.
Business Domain Pharmaceuticals, Biotechnology & Life Sciences | IPO Date 31st of August 2022 | Category Healthcare | Classification Health Care |
Shuttle Pharmaceuticals Holdings, Inc., through its subsidiary, Shuttle Pharmaceuticals, Inc., focuses on the discovery, development, and commercialization of drugs for sensitizing cancers to radiation therapy. The company was founded in 2012 and is based in Rockville, Maryland. The company has 6.26 M outstanding shares of which 25.66 K shares are at this time shorted by private and institutional investors with about 0.78 trading days to cover. More on Shuttle Pharmaceuticals
Moving together with Shuttle Stock
| 0.66 | EYEN | Eyenovia | PairCorr |
| 0.72 | IPA | Immunoprecise Antibodies | PairCorr |
| 0.69 | VOR | Vor Biopharma | PairCorr |
| 0.76 | MOLN | Molecular Partners | PairCorr |
Moving against Shuttle Stock
Follow Valuation Profit Patterns Odds of Bankruptcy
Check how we calculate scores
Shuttle Stock Highlights
| CoCEO CoFounder | Anatoly MD | ||||
| Business Concentration | Biotechnology, Pharmaceuticals, Biotechnology & Life Sciences, Health Care, NASDAQ Composite, NASDAQ Health Care, Health Care, Biotechnology, Drug Manufacturers—Specialty & Generic, Healthcare (View all Sectors) | ||||
Shuttle Pharmaceuticals can leverage the use of borrowed funds to amplify returns from an investment. In general, analyzing the relationship between debt to total assets helps investors to understand Shuttle Pharmaceuticals' financial leverage. It provides some insight into what part of Shuttle Pharmaceuticals' total assets is financed by creditors.
| |||||
Shuttle Pharmaceuticals (SHPH) is traded on NASDAQ Exchange in USA. It is located in 401 Professional Drive, Gaithersburg, MD, United States, 20879 and employs 9 people. Shuttle Pharmaceuticals is listed under Biotechnology category by Fama And French industry classification. The company currently falls under 'Nano-Cap' category with a current market capitalization of 2.64 M. Shuttle Pharmaceuticals conducts business under Biotechnology sector and is part of Health Care industry. The entity has 6.26 M outstanding shares of which 25.66 K shares are at this time shorted by private and institutional investors with about 0.78 trading days to cover.
Shuttle Pharmaceuticals currently holds about 50.44 K in cash with (7.33 B) of positive cash flow from operations.
Check Shuttle Pharmaceuticals Probability Of Bankruptcy
Ownership AllocationShuttle Pharmaceuticals has 18.22 % of its outstanding shares held by insiders and 6.14 % owned by institutional holders.
Check Shuttle Ownership Details
Shuttle Stock Institutional Holders
| Instituion | Recorded On | Shares | |
| Armistice Capital, Llc | 2024-12-31 | 306.1 K | |
| Ubs Group Ag | 2024-12-31 | 32.8 K | |
| Geode Capital Management, Llc | 2024-12-31 | 10.9 K | |
| Tower Research Capital Llc | 2024-12-31 | 6.9 K | |
| Federation Des Caisses Desjardins Du Quebec | 2024-12-31 | 63.0 | |
| Bank Of America Corp | 2024-12-31 | 23.0 | |
| Hrt Financial Llc | 2024-12-31 | 0.0 |
Shuttle Pharmaceuticals Historical Income Statement
Shuttle Stock Against Markets
Shuttle Pharmaceuticals Corporate Management
| Michael Starkweather | VP Devel | Profile | |
| CSC MD | Chief CoFounder | Profile | |
| Timothy CPA | Chief Officer | Profile | |
| BBA MBA | Interim Officer | Profile | |
| Gene Esq | General Counsel | Profile | |
| Mira Jung | CoFounder Biology | Profile |
Check out World Market Map to better understand how to build diversified portfolios, which includes a position in Shuttle Pharmaceuticals. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in american community survey. For more detail on how to invest in Shuttle Stock please use our How to Invest in Shuttle Pharmaceuticals guide.You can also try the Portfolio Rebalancing module to analyze risk-adjusted returns against different time horizons to find asset-allocation targets.
Is Biotechnology space expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of Shuttle Pharmaceuticals. If investors know Shuttle will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about Shuttle Pharmaceuticals listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
The market value of Shuttle Pharmaceuticals is measured differently than its book value, which is the value of Shuttle that is recorded on the company's balance sheet. Investors also form their own opinion of Shuttle Pharmaceuticals' value that differs from its market value or its book value, called intrinsic value, which is Shuttle Pharmaceuticals' true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because Shuttle Pharmaceuticals' market value can be influenced by many factors that don't directly affect Shuttle Pharmaceuticals' underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between Shuttle Pharmaceuticals' value and its price as these two are different measures arrived at by different means. Investors typically determine if Shuttle Pharmaceuticals is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, Shuttle Pharmaceuticals' price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.